STAURENZA

Details for Australian Trade Mark No. 1109443 (hide)

Owner Eli Lilly and Company a Indiana corporation

Convention US 17 November 2005 78/756176

Service Spruson & Ferguson

Various Convention priority claimed: 17 November 2005, United States of America, No. 78/756176 in respect of PHARMACEUTICAL PREPARATIONS NAMELY PHARMACEUTICAL PREPARATION FOR THE TREATMENT AND PREVENTION OF BLOOD DISORDERS, CANCER/ONCOLOGY, CARDIOVASCULAR DISEASE

Filing Date 18 April 2006

Classes

Class 5 Pharmaceutical preparations, including pharmaceutical preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous system diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders

Event Publications

11 May 2006 Application filed

11 May 2006 Application Accepted

7 September 2006 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1109444-HOPE AWARDS

1109442